Nouvelle déclaration d'incident
No de la demande: 2011-0834
Numéro de référence du titulaire d'homologation: PROSAR Case #1-24470404
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: MICHIGAN
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-126
Nom du produit: Advanced Care 2 in 1 Flea Tick Cat Spray
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Dog / Chien
Yorkshire Terrier
1
Homme
9
5
lbs
Cutanée
Unknown / Inconnu
>3 days <=1 wk / >3 jours <=1 sem
Système
Persisted until death
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-24470404- The reporter, a pet owner, indicates her animal was exposed to an insecticide containing the active ingredient tetrachlorvinphos. The pet owner indicated she applied the product; a flea and tick spray for cats, to her nine year five pound male Yorkshire terrier dog four days prior to the initial contact with the registrant. The owner indicates the animal demonstrated no signs until the day prior to the initial contact with the registrant. The animal was found in the home the day prior laying on his side struggling to breathe. The pet owner indicates when the animal was picked up it screamed in pain. The animal was brought to the veterinarian and treated for what was suspected to be an ¿¿¿allergic reaction? with unknown injectable medications. The pet owner indicated the animal became rigid while the veterinarian was working on it and began having seizures. The pet owner indicates the animal was left in the care of the veterinarian and several hours later they were called and told the seizures were not abating, the animal may have had a ¿¿¿heart attack? and it was ¿¿¿semi-comatose?. The pet owner indicated the veterinarian called in the morning and had stated the animal had died the prior evening. The pet owner was advised the onset and signs seen were both inconsistent with exposure to the active ingredient in the concentration seen. The pet owner was offered registrant supported cholinesterase testing and necropsy. She indicated she was not likely to pursue these diagnostics. No further information is available.
Mort